help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-0168
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bayatti, N.
Right arrow Articles by Behl, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bayatti, N.
Right arrow Articles by Behl, C.
Endocrinology Vol. 144, No. 9 4051-4060
Copyright © 2003 by The Endocrine Society

Brain Region-Specific Neuroprotective Action and Signaling of Corticotropin-Releasing Hormone in Primary Neurons

Nadhim Bayatti, Jürgen Zschocke and Christian Behl

Independent Research Group Neurodegeneration, Max Planck Institute of Psychiatry, 80804 Munich, Germany; and Institute of Physiological Chemistry and Pathobiochemistry, Johannes Gutenberg University Mainz, 55099 Mainz, Germany

Address all correspondence and requests for reprints to: Christian Behl, Ph.D., Institute of Physiological Chemistry and Pathobiochemistry, Johannes Gutenberg University Mainz, 55099 Mainz, Germany. E-mail: cbehl{at}uni-mainz.de.

CRH regulates the body’s response to stressful stimuli by modulating the activity of the hypothalamic pituitary axis. In primary cultures and cell lines, CRH also acts as a potent neuroprotective factor in response to a number of toxins. Using primary neuronal cultures from the cerebellum, cerebral cortex, and hippocampus, we demonstrate that CRH exerts a brain region-specific neuroprotective effect on amyloid ß 25–35 toxicity. At low CRH concentrations (10-8 M), neuroprotective effects can be observed only in cerebellar and hippocampal cultures, but a higher CRH concentration (10-7 M) additionally led to the protection of cortical neurons. These neuroprotective effects were inhibited by H89, a specific protein kinase A inhibitor. Western blot analysis, carried out using phospho-specific antibodies directed against MAPK, cAMP response element-binding protein (CREB), and glycogen synthase kinase (GSK)3ß also resulted in brain legion-specific differences regarding intracellular signaling. Correlating with cell survival, low CRH concentrations resulted in activation of the CREB pathway and inactivation of GSK3ß in cerebellar and hippocampal cultures, but higher concentrations additionally resulted in activated CREB and inactivated GSK3ß in cortical cultures. In contrast, MAPK activation occurred only in cortical neurons. Differences in signaling were found to be independent of receptor expression levels because RT-PCR analysis indicated no region-specific differences in CRHR1 mRNA expression.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
R. Hanstein, J. Trotter, C. Behl, and A. B. Clement
Increased Connexin 43 Expression as a Potential Mediator of the Neuroprotective Activity of the Corticotropin-Releasing Hormone
Mol. Endocrinol., September 1, 2009; 23(9): 1479 - 1493.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Bender, P. Hajieva, and B. Moosmann
From the Cover: Adaptive antioxidant methionine accumulation in respiratory chain complexes explains the use of a deviant genetic code in mitochondria
PNAS, October 28, 2008; 105(43): 16496 - 16501.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Sheng, T. Sun, B. Cong, P. He, Y. Zhang, J. Yan, C. Lu, and X. Ni
Corticotropin-releasing hormone stimulates SGK-1 kinase expression in cultured hippocampal neurons via CRH-R1
Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E938 - E946.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Sheng, Y. Zhang, J. Sun, L. Gao, B. Ma, J. Lu, and X. Ni
Corticotropin-Releasing Hormone (CRH) Depresses N-Methyl-D-Aspartate Receptor-Mediated Current in Cultured Rat Hippocampal Neurons via CRH Receptor Type 1
Endocrinology, March 1, 2008; 149(3): 1389 - 1398.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-J. Wang, S.-Z. Lin, J.-S. Kuo, H.-Y. Huang, S.-F. Tzeng, C.-H. Liao, D.-C. Chen, and W.-F. Chen
Urocortin Modulates Inflammatory Response and Neurotoxicity Induced by Microglial Activation
J. Immunol., November 1, 2007; 179(9): 6204 - 6214.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
E. W. Hillhouse and D. K. Grammatopoulos
The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology
Endocr. Rev., May 1, 2006; 27(3): 260 - 286.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Bayatti, H. Hermann, B. Lutz, and C. Behl
Corticotropin-Releasing Hormone-Mediated Induction of Intracellular Signaling Pathways and Brain-Derived Neurotrophic Factor Expression Is Inhibited by the Activation of the Endocannabinoid System
Endocrinology, March 1, 2005; 146(3): 1205 - 1213.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. S. Kreibich and J. A. Blendy
cAMP Response Element-Binding Protein Is Required for Stress But Not Cocaine-Induced Reinstatement
J. Neurosci., July 28, 2004; 24(30): 6686 - 6692.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society